Correction: Case Report: PD-1/CTLA-4 dual checkpoint blockade(QL1706) in advanced pulmonary squamous cell carcinoma complicated by multidrug-resistant tuberculosis after multiple lines of immunotherapy - Scorecard - MDSpire
Advertisement
Correction: Case Report: PD-1/CTLA-4 dual checkpoint blockade(QL1706) in advanced pulmonary squamous cell carcinoma complicated by multidrug-resistant tuberculosis after multiple lines of immunotherapy
Clinical Scorecard: Correction: Case Report on Dual PD-1/CTLA-4 Checkpoint Inhibition (QL1706) in Advanced Pulmonary Squamous Cell Carcinoma with Multidrug-Resistant Tuberculosis Following Multiple Immunotherapy Regimens
At a Glance
Category
Detail
Condition
Advanced Pulmonary Squamous Cell Carcinoma with Multidrug-Resistant Tuberculosis
Key Mechanisms
PD-1/CTLA-4 dual checkpoint blockade
Target Population
Patients with advanced pulmonary squamous cell carcinoma and multidrug-resistant tuberculosis
Care Setting
Oncology
Key Highlights
Correction of article type from 'Review' to 'Case Report'
Focus on dual PD-1/CTLA-4 checkpoint inhibition
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with advanced pulmonary squamous cell carcinoma and multidrug-resistant tuberculosis
